The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
N | Nervous system | |
2
|
N07 | Other nervous system drugs | |
3
|
N07X | Other nervous system drugs | |
4
|
N07XX | Other nervous system drugs | |
5
|
N07XX17 |
| Active Ingredient |
|---|
|
The mechanism(s) by which arimoclomol exerts its clinical effects in patients with NPC is unknown. |
| Document | Type | Information Source | |
|---|---|---|---|
| MIPLYFFA Capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) |